Clinical trial
Targeting ATR in Soft-tissue Sarcomas: a Randomized Phase II Study. TARSARC Study
NCT04807816 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting ATR in Soft-tissue Sarcomas: a Randomized Phase II Study. TARSARC Study
- Lead sponsor
- Institut Bergonié
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 9, 2022
- Completion date
- April 21, 2026
- Enrollment
- 58 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
leiomyosarcoma, adult